Диссертация (1140625), страница 21
Текст из файла (страница 21)
Horner, P. Time to manage Mycoplasma genitalium as an STI: but not withazithromycin 1 g! / P. Horner, K. Blee, E. Adams // Curr. Opin. Infect. Dis. 2014. – Vol.27. - № 1. – P. 68–74.140. Huppert, J. S. Mycoplasma genitalium detected by transcription-mediatedamplification is associated with Chlamydia trachomatis in adolescent women / J. S.Huppert, J. E. Mortensen, J. L. Reed [et al] // Sex.
Transm. Dis. – 2008. Vol. 35. – P.250–254.141. Jensen, J. S. European guideline on Mycoplasma genitalium infections / J.Jensen, M. Cusini, M. Gomberg [et al.] // Eur. Acad. Dermatol. Venerol. – 2016. - Vol.30. - № 10. - P. 1650 – 1656.142. Jensen, J. S. Management of Mycoplasma genitalium infections – can wehit a moving target? / J. S. Jensen, C. Bradshaw // BMC Infect. Dis.
– 2015. –Vol. 15.P. 343.143. Jensen,A.Chlamydiatrachomatis,MycoplasmagenitaliumandUreaplasma urealyticum among students in northern Norway / A. Jensen, C. Kleveland,122A. Moghaddam [et al.] // Jour. Eur. Acad. Dermatol. Venereol. – 2013. - Vol. 27. - №1.
- P. 91 – 96.144. Jernberg, E. Azithromycin and moxifloxacin for microbiological cure ofMycoplasma genitalium infection: an open study / E. Jernberg, A. Moghaddam, H. Moi// Int. J. STD. AIDS. – 2008. - Vol. 19. - № 10. – P. 676–679.145. Johnston-MacAnanny, E. B. Chronic endometritis is common inwomen with recurrent implantation failure after in vitro fertilization / E. B.Johnston-MacAnanny, J. Hartnett, L.
L. Engmann // Fertil Steril. - Vol. 93. - № 2.– P. 437-441.146. Kenny, G. E. Genital mycoplasmas: Mycoplasma genitalium, Mycoplasmahominis, and Ureaplasma species / G. E. Kenny // Principles and practice of infectiousdiseases, 2010. – P. 2491–2493.147. Kim, S. J.
Effects of infections with five sexually transmitted pathogens onsperm quality / S. J. Kim, D. J. Paik, J. S. Lee // Clin. Exp. Reprod. Med. – 2017. - Vol.44. - № 4. - P. 207 – 213.148. Koumans, E. H. The prevalence of bacterial vaginosis in the United States,2001-2004: associations with symptoms, sexual behaviors, and reproductive health / E.H.
Koumans, M. Sternberg, C. Bruce [et al.] // Sex. Transm. Dis. - 2007. – Vol. 34. – P.864–869.149. Lallemand, A. Prevalence of Mycoplasma genitalium in patients visitingHIV counselling institutions in North-Rhine-Westphalia, Germany (STI-HIT study) / A.Lallemand, V. Bremer, K. Jansen // Sex. Transm. Infect. – 2015. - Vol. 91.
- № 2. - P.150.150. Li, C. Risk factors for ectopic pregnancy: a multicenter case-control study /C. Li, W. H. Zhao, Q. Zhu // BMC Pregnancy Childbirth. - 2015. – Vol.15. – P. 187.151. Lillis, R. A. Utility of urine, vaginal, cervical, and rectal specimens fordetection of Mycoplasma genitalium in women / R. A. Lillis, M. J. Nsuami, L. Myers[et al.] // J. Clin. Microbiol. – 2011. - Vol. 49. - № 5.
- P. 1990–1992.123152. Lis, R. Mycoplasma genitalium infection and female reproductive tractdisease: a meta-analysis / R. Lis, A. Rowhani-Rahbar, L. Manhart // Clin. Infect. Dis. 2015. - Vol. 61. - № 3. - P. 418-426.153. Lefebvre, M. Prevalence of Mycoplasma genitalium infection andrelationship with symptoms among adults attending a sexual health centre / M.Lefebvre, J. Coutherut, S. Gibaud [et al.] // Acta Derm. Venereol. – 2017.
- Vol.97 №4. - P. 543-545.154. Le Roux, M. Quantitative real-time polymerase chain reaction for thediagnosis of Mycoplasma genitalium infection in south african men with and withoutsymptoms of urethritis / M. Le Roux, A. Hoosen // Sex Transm. Dis. – 2017. - Vol. 44.- № 1. - P. 17-20.155. Le Roy, C. French prospective clinical evaluation of the AptimaMycoplasma genitalium CE-IVD assay and macrolide resistance detection using threedistinct assays / C. Le Roy, S. Pereyre, N.
Henin / J. Clin. Microbiol. – 2017. - Vol. 55 № 11. - P. 3194-3200.156. Lokken, E. Association of recent bacterial vaginosis with acquisition ofMycoplasma genitalium / E. Lokken, J. Balkus // Am. J. Epidemiol. – 2017. – Vol.186.- №2. – P. 194-201.157. Ma, L. Extensive variation and rapid shift of the MG192 sequence inMycoplasma genitalium strains from patients with chronic infection / L. Ma, M.Mancuso, J.A.
Williams [et al.] // Infect. Immun. – 2014. – Vol. 82. – P. 1326–1334.158. Manhart, L. High Mycoplasma genitalium organism burden is associatedwith shedding of HIV-1 DNA from the cervix / L. Manhart, S. Mostad, J. Baeten [et al.]// J. Infect. Dis. – 2008. - Vol. 197. - P.733-736.159. Manhart, L. Mycoplasma genitalium: should we treat and how? / L.Manhart, J. Broad, M.
Golden // Clinical. Infectious Diseases. - 2011. – Vol. 53. - №3. P.129-142.160. Manhart, L. Standard treatment regimens for nongonococcal urethritis havesimilar but declining cure rates: a randomized controlled trial / L. Manhart, C. Gillespie,M. Lowens [et al.] // Clin. Infect. Dis. - 2013. – Vol.
56. – P. 934–944.124161. Manhart, L. Mycoplasma genitalium: an emergent sexually transmitteddisease? / L. Manhart // Infectious Disease Clinics of North America. - 2013. – Vol. 27.- № 4. – P. 779–792.162. Mascarenhas, M. N. National, regional, and global trends in infertilityprevalence since 1990: а systematic analysis of 277 health surveys / M.
N.Mascarenhas, S.R. Flaxman, T. Boerma [et al.] // PLoS Med. – 2012. – URL:https://www.ncbi.nlm.nih.gov/pubmed/23271957 (date of the application 13.09.2017).163. Mavedzenge, S. Association of Mycoplasma genitalium and HIV infection:a systematic review and meta-analysis / S. Mavedzenge, H. Weiss //AIDS. – 2009. –Vol.
23. – P. 611-620.164. Mavedzenge, S. The association between Mycoplasma genitalium andHIV-1 acquisition in African women / S. Mavedzenge, B. Van Der Pol, H. Weiss [et al.]// AIDS. – 2012. – Vol. 26. – P. 617-624.165. Mavedzenge, S. Mycoplasma genitalium is associated with increasedgenital HIV type 1 RNA in Zimbabwean women / S. Mavedzenge, E. Muller, D. Lewis[et al.] // J. Infect. Dis. – 2015.
– Vol. 211.- P. 1388-1398.166. McGowin, C. Mycoplasma genitalium: an emerging cause of sexuallytransmitted disease in women [Electronic resource] / C. McGowin, C. Anderson-Smits//PLoSPathog.–2011.–URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102684/ (date of the application27.11.2017).167. McGowin, C. Mycoplasma genitalium infection activates cellular hostdefense and inflammation pathways in a 3-dimensional human endocervical epithelialcell model / C.
McGowin, A. Radtke, K. Abraham [et al.] // J. Infect. Dis. – 2013. - Vol.207. - №12. - P. 1857-1868.168. McGowin, C. Mycoplasma genitalium rapidly disseminates to the upperreproductive tracts and knees of female mice following vaginal inoculation / C.McGowin, R.A. Spagnuolo, R.B. Pyles // Infect. Immun. – 2010. – Vol. 78.
– P. 726–736.125169. McGowin, C. Persistent Mycoplasma genitalium infection of humanendocervical epithelial cells elicits chronic inflammatory cytokine secretion / C.McGowin, R. Annan, A. Quayle [et al.] // Infect. Immun. – 2012. - Vol. 80. - №11. - P.3842-3849.170. McGowin, C. The unique microbiology and molecular pathogenesis ofMycoplasma genitalium / C. McGowin, P. Totten// J. Infect. Dis.– 2017.
- Vol. 216. №2. - P. 382-388.171. Mena L. A. A randomized comparison of azithromycin and doxycycline forthe treatment of Mycoplasma genitalium-positive urethritis in men / L. A. Mena, T. F.Mroczkowski, M. Nsuami // Clin Infect Dis. – 2009. – Vol. 48. - № 12.
- P. 1649–1654.172. Mo, X. Prevalence and correlates of Mycoplasma genitalium infectionamong prostatitis patients in Shanghai, China [Electronic resource] / X. Mo, C. Zhu, J.Gan[etal.]//SexHealth.–2017.-URL:https://www.ncbi.nlm.nih.gov/pubmed/27372963/ (date of the application 27.11.2017).173. Mobley, V.L. Mycoplasma genitalium infection in women attending asexually transmitted infection clinic: diagnostic specimen type, coinfections, andpredictors / V.L. Mobley, M.M. Hobbs, K. Lau, B.S.
Weinbaum [et al.] // Sex. Transm.Dis. - 2012. - Vol. 39. - № 9. – P. 706-709.174. Moi, H. Mycoplasma genitalium in women with lower genital tractinflammation / H. Moi, N. Reinton, A. Moghaddam // Sex. Transm. Infect. – 2009. Vol. 85. - № 1. – P. 10-14.175. Munson, E. Clinical laboratory assessments for Mycoplasma genitalium ina high-prevalence sexually-transmitted infection community reveal epidemiologicdichotomies with Trichomonas vaginalis / E. Munson, K. Munson, R. Schell // Expert.Rev. Anti Infect.
Ther. – 2017. - Vol. 15. - № 2. – P. 133-145.176. Munson, E. Clinical laboratory assessments of Mycoplasma genitaliumTranscription-Mediated Amplification Using Primary Female Urogenital Specimens / E.Munson, H. Bykowski, K. L. Munson // J. Clin. Microbiol. – 2016. - Vol. 54. - № 2. –P. 432-438.126177. Munson, E. Molecular diagnostics update for the emerging (if not alreadywidespread) sexually transmitted infection agent Mycoplasma genitalium: just aboutready for prime time // J.















